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Background: HPTN 071 (PopART) was a community-
randomized trial of a universal testing-and-treatment intervention
on HIV incidence at population level in Zambia and South Africa. In
Zambia, a trial of community-based distribution of HIV self-testing
(HIVST) kits, including secondary distribution, as an option for
HIV-testing was nested within 4 PopART intervention communities.
We used data from the intervention arm of the nested trial to measure
levels of and factors associated with acceptance and use of secondary
distribution HIVST kits.
Methods: Community HIV care providers offered the PopART
combination HIV-prevention intervention door-to-door, systematically
visiting all households and enumerating all household members. From 1
February to 30 April 2017, individuals aged 16 years and older
consenting to PopART were offered the option to HIV self-test, if
eligible for HIV-testing services. Individuals aged 18 years and older who
reported a partner absent during household visits were offered an HIVST
kit for secondary distribution to this partner. We used two data sources to
measure acceptance and use of secondary distribution HIVST kits.
Results: Among 9105 individuals aged 18 years and older consent-
ing to PopART, 9.1% (n = 825) accepted an HIVST kit for secondary
distribution. Approximately 55.8% reported that the kit had been used.
Women were more likely to accept, and men more likely to use,
secondary distribution HIVST kits. Kits were more likely to be used
by individuals aged 30+ and who had not participated in a previous
round of PopART. Approximately 6.8% had a reactive result.
Conclusions: Community-based secondary distribution of HIVST
kits reached men absent during community HIV care provider
household visits and is a complement to facility- and community-
based HIV-testing services, which often miss men.
Key Words: HIV self-testing, men, HIV testing, Zambia, sub-
Saharan Africa
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INTRODUCTION
Testing for HIV facilitates entry into the treatment
continuum and access to prevention services. Despite its
centrality to service access, in 2017, one-quarter of individ-
uals remained unaware of their HIV-positive status globally.1
In sub-Saharan Africa, men are among those not being
reached by HIV services. Of individuals living with HIV,
;58% of boys/men know their HIV-positive status compared
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with 78% of girls/women.2 Drivers of men’s low uptake of
HIV-testing services are multifaceted, including health sys-
tem and economic factors, and masculinity norms.3–5 As
a consequence, HIV-positive men experience higher morbid-
ity and mortality than HIV-positive women,2 and risk onward
transmission to sexual partners.6–8 In Zambia in 2015/16,
viral load suppression among individuals aged 25–34 was
.50% among women and ;35% among men.2,9 Reducing
morality and reaching the UNAIDS 90-90-90 targets of zero
HIV transmission requires a concerted effort to reach
everyone with HTS, including men.
Since 2016, WHO has supported the implementation of
evidence-based strategies to deliver HIV self-testing
(HIVST).10–13 Through increased autonomy about when
and where to test, HIVST has the potential to increase HIV-
testing coverage among men and other groups not reached by
available HTS. Secondary distribution of HIVST, where an
HIVST kit is given to an individual for distribution to a third
party, has been shown to reach male partners of women
attending health facilities and can facilitate couples-test-
ing.14,15 To date, there is little evidence on community-
based secondary distribution of HIVST.
HPTN 071 (PopART) was a community-randomized
trial of a universal testing-and-treatment (UTT) intervention
on HIV incidence at population level.16 After 2 years of
service delivery in Zambia, PopART reached the first
UNAIDS 90% target among HIV-positive women, approach-
ing it among men.17 A challenge was reaching men aged
25–54 years, who were often absent during home-based
service delivery.17,18 To address this gap, a cluster-
randomized trial (CRT) of HIVST as an alternative choice
for how to test for HIV was nested in 4 Zambian PopART
communities.19 Overall, the HIVST intervention showed
a small but significant increase in knowledge of HIV status
among men.20 As part of the HIVST intervention, individuals
whose partner (a household member who is a spouse/
cohabiting partner) was absent during lay counselor’s house-
hold visits were offered an HIVST kit for distribution to this
partner. This strategy primarily aimed to reach men18 and
support couples-testing. Analysis of the primary outcome
found that 14% of men who self-tested did so using
a secondary distribution HIVST kit.20
Using data from the nested HIVST trial, we describe
characteristics of individuals who accepted an HIVST kit for
secondary distribution and, among these individuals, describe
characteristics associated with reporting use of the kit. We
describe return of secondary distribution HIVST kits and
characteristics of individuals who used these kits. We use
findings to provide recommendations for implementation of
secondary distribution outside of health facilities as part of
a UTT strategy.
METHODS
Study Location and Population
HPTN 071 (PopART) was conducted from 2014 to
2017 in South Africa and Zambia. In Zambia, HPTN 071
(PopART) was implemented in 12 communities, defined as
the catchment population of a government primary health care
facility.16 The HIVST CRT was nested in 4 communities that
were randomized to receive the PopART intervention.
Communities randomized to receive the PopART intervention
were divided into geographical “zones” of ;450–500
households. Within each zone, a pair of trained lay counse-
lors, called community HIV care providers (CHiPs), delivered
PopART systematically to each household within their
zone.16 In the 4 PopART communities included in the HIVST
nested trial, restricted randomization was used to allocate 66
zones to either rapid HIV-testing on a finger-prick blood
sample performed by a CHiP (PopART standard of care) or
the PopART intervention plus the offer of HIVST.20
Details of the nested CRT are published elsewhere.20
Briefly, all individuals aged 16 years and older, resident in
a household in the 4 communities and enumerated during the
HIVST intervention (February 1-April 30, 2017, during a third
round of PopART) were eligible to participate in the HIVST
trial.16,20 For this analysis, we used data only from 33 zones
allocated to the PopART plus HIVST intervention.
The PopART Plus HIVST Intervention
The PopART intervention included door-to-door deliv-
ery of HTS with referral to care and immediate treatment for
individuals testing HIV-positive or to prevention services for
individuals testing HIV-negative.16 During household visits,
CHiPs used electronic data capture (EDC) devices to
systematically enumerate all households within their zones
and collect data on services offered to and used by household
members consenting to PopART.18,21 CHiPs offered HTS to
individuals who reported that their last HIV test was negative
or that they had never HIV tested. During the HIVST
intervention period, when offering HTS to eligible individu-
als, CHiPs offered the option of either finger-prick HIV
testing or oral HIVST.20 Individuals choosing HIVST could
choose supervised HIVST in the presence of the CHiP or
unsupervised HIVST.20
For individuals aged 18 years and older who consented
and whose spouse/partner was absent at the time of the
household visit, CHiPs offered to leave HIVST kit(s) for
secondary distribution to this partner (the intended user) or for
couples-testing with this partner (Fig. 1). CHiPs informed
intermediary individuals, defined as individuals accepting
a secondary distribution HIVST kit, that they should provide
the intended user with information on how to perform and
read the self-test and not force them to use the self-test.24
CHiPs also informed intermediary individuals that used (or
unused) kits could be returned either to the CHiP or dropped
off confidentially at the clinic. CHiPs left a card with contact
details for additional support if needed. Within 7 days of
leaving an HIVST kit, CHiPs conducted a follow-up visit. If
the intended user was absent during follow-up, the interme-
diary individual was asked about use and results of the self-
test. Data from follow-up visits were collected until 30
June 2017.
The HIVST package included an OraQuick kit, sealable
envelope, and self-completed results (SCR) form, which
asked age, sex, the self-test result, and questions on ease of
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kit use. The envelope intended to facilitate confidential return
of HIVST kits and SCR forms. At the health facility, the
study team installed a box where the envelope could be
dropped off. All 3 items were labeled with the same unique
barcode to allow the SCR form, the HIVST kit, and data on
the intermediary individual who collected the secondary
distribution HIVST kit to be linked.
A database of returned HIVST kits was developed to
monitor kit return. This database included data on every
HIVST kit returned to CHiPs/health facilities, including the
HIVST barcode, whether the test had been used and the
information available on the SCR form.
Data Collection
The EDC used by CHiPs was modified to collect data
for analysis of the primary outcome of the nested HIVST
trial.21 Relevant to this analysis, modifications allowed CHiPs
to record: whether an individual accepted an HIVST kit for
secondary distribution, the unique barcode of the kit, and the
intermediary individual’s report of kit use. For each house-
hold member, data were available on whether the household
member was absent at the time of a CHiP household visit and/
or had used a secondary distribution HIVST kit. There were
no data on the relationship between household members and
so no data on the number of individuals consenting to
PopART who had a partner absent during the CHiP
household visit.
In their EDC, the CHiP was expected to record the
result of the secondary distribution HIVST kit CHiP, if the
intermediary individual reported that the kit had been used by
an enumerated household member and they knew the result,
to facilitate follow-up visits for HIV-related services, includ-
ing confirmatory HTS.
Study Outcomes
This analysis includes 4 outcomes. The first is the
number and percentage of household members accepting an
HIVST kit for secondary distribution (numerator) among
individuals aged 18 years and older who consented to
PopART (denominator). The second is the number and
percentage of intermediary individuals who reported use of
the HIVST kit, defined as reporting that the kit was used and/
or reporting the self-test result to the CHiP (numerator)
among the number of household members accepting an
HIVST kit for secondary distribution (denominator).
The third outcome is the number and percentage of
individuals for whom there is evidence that a secondary
HIVST kit was used (numerator), among the denominator of
all individuals absent at the first CHiP household visit
(evidence of use outcome). This outcome used both data
sources and was defined as either the HIVST kit returned used
with a result entered on the SCR (recorded as negative,
reactive, or indeterminate) or a secondary distribution HIVST
kit result recorded by the CHiP (as reported by the
intermediary individual or the intended user, if seen by
the CHiP).
The fourth outcome is the number and percentage of
individuals who used a secondary distribution HIVST kit and
were enumerated by, and therefore known to, the CHiP
(numerator), among individuals absent at the first CHiP
household visit (denominator). In contrast to outcome 3, this
outcome used EDC data only. The numerator included only
FIGURE 1. Schematic illustrating the
distribution and return of secondary
distribution HIVST kits.
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individuals who had a secondary distribution HIVST kit
result recorded by the CHiP.
Of note, the number of kits reported as used by the
intermediary individual (outcome 2) is higher than the
number of household members with a result reported to the
CHiP (outcome 4). There are 3 possible reasons for this
discrepancy: (1) the user of the kit was not a household
member and not enumerated by the CHiP, (2) although the
intermediary individual knew the kit had been used, they may
not have known the result, or (3) the CHiP did not record the
result in their EDC despite it being reported to them.
Data Limitations
The EDC system had been used by CHiPs for 3 years.
Changes to the system for this brief HIVST study were
kept minimal. As such, and as PopART was a UTT strategy,
household enumeration was not modified to record relation-
ships between individuals within households. Data on the
number of household members with a partner absent at the
first CHiP household visit were not available.
Despite minimal changes, some CHiPs experienced
challenges in data entry. Our analysis revealed that an
intermediary individual might be recorded as accepting an
HIVST kit for secondary distribution, yet there was no record
of any absent household member; alternatively, a result for
a secondary distribution HIVST kit was recorded for an
individual but with no record of an intermediary individual in
the household accepting a secondary distribution HIVST kit.
CHiPs recorded secondary distribution HIVST kit
results for 323 household members.20 For 47 (14.6%; n =
47/323), there was no record of an intermediary individual
who accepted a secondary distribution HIVST kit. Thirteen of
these individuals had performed supervised HIVST with the
CHiP and 2 self-reported their HIV-positive status. Adjusting
for these individuals gave 276 individuals with a secondary
distribution HIVST kit result, who were known to the CHiP
and linked to an intermediary individual.
Statistical Analysis
We describe and present in a flowchart the number of
intermediary individuals and the number of individuals who
report that the HIVST kit was used, not yet used (but the kit
was expected to be used), or not used (and the kit was not
expected to be used). We subsequently used the EDC and
return of HIVST kit data to describe the number of secondary
distribution HIVST kits that were returned and the number of
kits for which there was evidence of use.
We next describe all outcomes and, for outcomes one
and 2, explore the association between the intermediary
individual’s age, sex, previous residence in the CHiP zone,
HIV status as recorded by the CHiP, previous participation in
PopART and community of residence, and the outcomes. We
also explored whether uptake of an offer of HTS and the type
of HIV testing were associated with outcomes. For outcome
4, we explored the association between age, sex, previous
residence in the CHiP zone, HIV status as recorded by the
CHiP, previous participation in PopART, and community of
residence of individuals absent at first household visit and the
outcome. We used population-averaged models, allowing for
clustering by zones and adjusting a priori for age group and
sex, and for community to explain some of the between-zone
variation, to investigate these associations.
RESULTS
CHiPs recorded 834 household members as intermedi-
ary individuals. For 26 of these individuals, the kit was used
by a household member present at the time of the CHiP’s
visit. These were not counted as secondary distribution in
subsequent analysis. We also identified 47 individuals who
had a result for a secondary distribution HIVST kit recorded,
but no household member seen by the CHiP was listed as an
intermediary individual. For 17, we were able to use
household enumeration data to identify the intermediary
individual likely to have accepted the secondary distribution
HIVST kit.
After these adjustments, 825 individuals were defined
as intermediary individuals (Fig. 1) among whom 55.8% (n =
460/825) reported use and/or the result of the secondary
distribution HIVST kit to the CHiP (Fig. 2). Twenty-eight-
percent (n = 129/460; 28.0%) of these intermediary individ-
uals were recorded as having received counseling as a couple
or household.
One-quarter of intermediary individuals reported that
the kit had not yet been used (n = 199/825; 24.1%), 19.8% (n
= 163/825) that the kit would not be used, and for 0.4% (n =
3/825), data on use were missing. Of the 362 HIVST kits that
intermediary individuals reported were not yet or would not
be used, 34.5% (n = 125) were returned used (Fig. 2). For 102
(12.4%; n = 102/825) kits, there was no report that the kit had
been used nor were the kits identified in the returned HIVST
kit database.
Overall, there was evidence of use for 65.9% (n = 544) of
the 825 secondary distribution HIVST kits (Fig. 2). The majority
of kits were used by men (n = 448/541; 82.8%) and individuals
aged 30 years and older (n = 368/534; 68.9%; Tables 3 and 4);
overall, 6.8% (n = 37/544) of kits had a reactive result recorded
by the CHiP or on the SCR form; of these kits, 6 (16.2%)
intended users were subsequently seen by the CHiP.
Outcomes 1 and 2: Acceptance and Reported
Use of a Secondary Distribution HIVST Kit by
Intermediary Individuals
Among 9105 individuals aged 18 years and older
residing in zones randomized to the HIVST intervention
and consenting to participate in PopART, 9.1% (n = 825)
accepted an HIVST kit for secondary distribution. Women (n
= 738/5428; 13.6%) were more likely than men (n = 87/3677;
2.4%) to be intermediary individuals [adjusted odds ratio
(adjOR) = 7.02 95% confidence interval (CI): 5.07 to 9.72].
Acceptance of a secondary distribution HIVST kit was
highest among household members aged 25–39. Two
percent (n = 17/942; 1.8%) of individuals self-reporting
their HIV-positive status were intermediary individuals
compared to 9.9% (n = 808/8163) of individuals who
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reported never-testing or that their last HIV-test result was
negative. Among individuals accepting an offer of HTS,
individuals opting for unsupervised HIVST (n = 146/488;
29.9%) were more likely to be intermediary individuals
relative to those choosing finger-prick HTS (n = 137/3154;
4.3%, adjOR = 10.56 95% CI: 7.30 to 15.27; Table 1).
Intermediary individuals younger than 40 years and
who accepted an offer of HTS themselves were more likely to
report that the secondary distribution HIVST kit had been
used (Table 2). Among intermediary individuals who
accepted an offer of HTS themselves, those choosing
unsupervised HIVST were more likely to report use than
individuals who chose finger-prick HTS for themselves.
Outcome 3: Evidence of Use of Secondary
Distribution HIVST Kits
Forty-five percent of enumerated individuals (n = 5930/
13,267; 44.7%) were absent at the first CHiP household visit.
Using the definition of evidence of use, 9.2% (n = 544/5930)
of individuals absent at the first household visit were
estimated to have used a secondary distribution HIVST kit.
Outcome 4: Use of Secondary Distribution
HIVST Kits by Individuals Known to CHiPs
Among individuals enumerated by CHiPs but absent at
the first household visit, men (0.9% among women vs 6.9%
among men adjOR = 0.14, 95% CI: 0.09 to 0.21),
individuals aged 30 years and older (adjOR = 2.00 95%
CI: 1.38 to 2.90), previously not resident in the CHiP zone,
and who did not participate in a second round of PopART
were more likely to use secondary distribution HIVST kits
(Tables 3 and 4).
DISCUSSION
Community-based secondary distribution HIVST kits
were used by men and reached individuals who previously
had not participated in PopART. Although many secondary
distribution HIVST kits were returned, some were unused
while, for others, use was unknown. Few individuals with
a reactive self-test were subsequently seen by the CHiP
during the study period. Secondary distribution strategies that
are targeted at key demographic groups may minimize waste
and increase reach and should be considered as part of
a UTT strategy.
This is one of the first studies of secondary distribution
outside of health facility settings and adds to the evidence
base that the strategy is acceptable and can reach groups not
reached through home-based HTS. In 2 studies in Kenya,
health care workers offered female sex workers attending
drop-in clinics15 and women attending antenatal or post-
partum clinics an HIV self-test to distribute to sexual partners
or other individuals.14,15 The trial reported a significant
increase in partner-testing relative to invitations for clinic-
based HTS.14 Men resident in zones included in this analysis
reported that avoiding queues and “being seen” at the clinic
FIGURE 2. Flowchart describing the number and percent of intermediary individuals who reported use of secondary distribution
HIVST kits, HIVST kits returned and used.
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were advantages of secondary distribution, in addition to
allowing men to test at convenient times.23 Studies have
shown that (non)-monetary costs associated with accessing
facility-based HTS is particularly high for men.5,24
Community-based secondary distribution of HIVST over-
came some of these barriers and is important in settings where
men are under-reached.
Some secondary distribution HIVST kits were returned
unused or their use was unknown. At present, HIVST kits are
more expensive than rapid finger-prick HIV-tests. To reduce
costs, targeted secondary distribution should be implemented.25
In antenatal care, this could be secondary distribution to women
whose partner does not respond to invitations for HTS at health
facilities. Outside of health facilities, this could be distribution to
TABLE 1. Characteristics of Individuals Aged 18 Years and Older Contacted and Consenting to Participate in PopART (N = 9105)
















Overall 9105 825 9.1
Sex
Male 3677 40.4% 87 2.4% 1.0 1.0 ,0.001
Female 5428 59.6% 738 13.6% 6.24 (4.64 to 8.37) 7.02 (5.07 to 9.72)
Age
18–24 3016 33.1% 223 7.4% 1.0 1.0 ,0.001
25–29 1471 16.2% 219 14.9% 2.13 (1.59 to 2.85) 2.05 (1.51 to 2.78)
30–39 2093 23.0% 256 12.2% 1.71 (1.32 to 2.22) 1.68 (1.28 to 2.22)
40–49 1149 17.5% 85 7.4% 1.01 (0.75 to 1.37) 0.98 (0.68 to 1.39)
50+ 1376 15.1% 42 3.1% 0.43 (0.31 to 0.59) 0.37 (0.26 to 0.53)
Previously resident in the same CHiP zone
No 2620 28.8% 286 10.9% 1.0 1.0 0.03
Yes 6485 71.2% 539 8.3% 0.74 (0.60 to 0.90) 0.78 (0.63 to 0.98)
HIV status as reported to CHiP
Never self-reported HIV+ 8163 89.7% 808 9.9% 1.0 1.0 ,0.001
Ever self-reported HIV-positive 942 14.3% 17 1.8% 0.18 (0.11 to 0.30) 0.10 (0.05 to 0.20)
Accepted HTS among individuals eligible for HTS (not
self-reported HIV-positive; n = 8163)
No 1196 14.7% 66 5.5% 1.0 1.0 ,0.001
Yes 6967 85.3% 742 10.7% 2.33 (1.67 to 3.26) 2.59 (1.81 to 3.71)
Type of HTS among individuals eligible for and
accepting HTS (not self-reported HIV-positive; n =
6967)
Finger prick (no HIVST) 3154 45.3% 137 4.3% 1.0 1.00 ,0.001
Supervised HIVST 3325 47.7% 459 13.8% 3.69 (2.86 to 4.76) 3.71 (2.78 to 4.94)
Unsupervised HIVST 488 7.0% 146 29.9% 8.85 (6.22 to 12.57) 10.56 (7.30 to 15.27)
Participation and knowledge of HIV status in previous
rounds of PopART service delivery§
Did not participate in round 1 (R1)/round 2 (R2) of
PopART
3037 33.4% 307 10.1% 1.0 1.0 ,0.001
Not HIV-tested in R1/R2 836 9.2% 62 7.4% 0.66 (0.43 to 1.04) 0.68 (0.42 to 1.11)
Tested HIV negative in R1/R2 4494 49.4% 446 9.9% 1.02 (0.81 to 1.28) 1.02 (0.81 to 1.27)
Known HIV+ at R1/R2 738 8.1% 10 1.4% 0.14 (0.09 to 0.21) 0.08 (0.04 to 0.14)
Community number
1 2372 26.1% 200 8.4% 1.0 1.00 0.002
2 1101 12.1% 141 12.8% 1.60 (1.12 to 2.30) 1.78 (1.11 to 2.86)
3 3047 33.5% 321 10.5% 1.23 (0.79 to 1.90) 1.35 (0.78 to 2.32)
4 2585 28.4% 163 6.3% 0.77 (0.48 to 1.22) 0.56 (0.27 to 1.16)
R refers to rounds of PopART service delivery (R1—round 1, R2—round 2); the current study was nested in a third round of PopART service delivery.
*Accounting for clustering by zone.
†Adjusted for sex, age, and community, and accounting for clustering by zone.
‡P value from the Wald test.
§Either self-reported HIV-positive or newly diagnosed HIV-positive.
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individuals accessing community-based HTS who report a part-
ner whose HIV status they do not know or who last tested HIV-
negative .12 months ago or through social networks. To
encourage kit return and support linkage to services, non-
financial incentives or nudges or use of SMS reminders could be
explored. Fewer HIV-positive individuals had an absent house-
hold member, and few accepted a secondary distribution
HIVST. With evidence that secondary distribution through
index antiretroviral therapy patients increased partner-testing in
Malawi,26 community-based secondary distribution strategies
should offer more support for HIV-positive individuals to accept
secondary distribution HIVST kits.
Measuring use of HIVST kits, which are intended for
use in private, is challenging particularly with secondary
distribution. In the 2 Kenyan studies, outcomes were
reported by intermediary individuals.14,15 Our evidence of
use measure combined individual report and data on HIVST
kit return. Data from individuals only would have
TABLE 2. Characteristics of Intermediary Individuals (N = 825) Who Reported That the Secondary Distribution HIV Self-Test











Overall 825 460 55.8%
Sex
Male 87 10.5% 50 57.5% 1.0 1.0 0.07
Female 738 89.5% 410 55.6% 0.87 (0.56 to 1.35) 0.66 (0.42 to 1.04)
Age
18–24 223 27.0% 132 59.2% 1.0 1.0 0.01
25–29 219 26.5% 126 57.5% 0.91 (0.60 to 1.38) 0.90 (0.59 to 1.38)
30–39 256 31.0% 148 57.8% 0.92 (0.66 to 1.28) 0.86 (0.61 to 1.20)
40–49 85 10.3% 40 47.1% 0.61 (0.36 to 1.06) 0.56 (0.33 to 0.97)
50+ 42 5.1% 14 33.3% 0.37 (0.19 to 0.70) 0.31 (0.15 to 0.63)
Previously resident in the same CHiP zone
No 286 34.7% 164 57.3% 1.0 1.0 0.86
Yes 539 65.3% 296 54.9% 0.90 (0.62 to 1.30) 0.97 (0.65 to 1.43)
HIV status as reported to CHiP
Ever self-reported HIV+ 17 2.1% 8 47.1% 1.0 1.0 0.35
Never self-reported HIV-positive 808 97.9% 452 55.9% 0.68 (0.33 to 1.40) 0.70 (0.33 to 1.48)
Accepted HTS among individuals eligible for HTS (not
self-reported HIV-positive; N = 808)
No 66 8.0% 15 22.7% 1.0 1.0 ,0.001
Yes 742 89.9% 437 59.0% 5.21 (2.69 to 10.06) 5.32 (2.73 to 10.38)
Type of HTS among individuals eligible for and
accepting HTS (not self-reported HIV-positive; n =
742)
Finger prick (no HIVST) 137 16.6% 65 47.4% 1.0 1.0 ,0.001
Supervised HIVST 459 55.6% 254 55.3% 1.40 (0.94 to 2.07) 1.37 (0.91 to 2.07)
Unsupervised HIVST 146 17.7% 118 80.8% 4.50 (2.67 to 7.58) 4.49 (2.52 to 7.99)
Participation and knowledge of HIV status in previous
rounds of PopART service delivery
Did not participate in round 1 (R1)/round 2 (R2) of
PopART
307 37.2% 174 56.7% 1.0 1.0 0.18
Not HIV-tested in R1/R2 62 7.7% 36 58.1% 0.99 (0.60 to 1.63) 1.06 (0.63 to 1.77)
Tested HIV-negative in R1/R2 446 54.1% 248 55.6% 0.95 (0.66 to 1.37) 1.03 (0.71 to 1.51)
Known HIV+ at R1/R2§ 10 1.2% 2 20.0% 0.18 (0.04 to 0.90) 0.18 (0.04 to 0.88)
Community number
1 200 24.2% 105 52.5% 1.0 1.0 0.02
2 141 17.1% 93 66.0% 1.77 (1.11 to 2.80) 1.84 (1.16 to 2.93)
3 321 38.9% 179 55.8% 1.09 (0.63 to 1.90) 1.10 (0.64 to 1.89)
4 163 19.8% 83 50.9% 0.92 (0.54 to 1.54) 0.95 (0.56 to 1.61)
R refers to rounds of PopART service delivery (R1—round 1, R2—round 2); the current study was nested in a third round of PopART service delivery.
*Accounting for clustering by zone.
†Adjusted for sex, age, and community, and accounting for clustering by zone.
‡P value from the Wald test.
§Either self-reported HIV-positive or newly diagnosed HIV-positive.
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underestimated use. Underreporting of kit use by interme-
diary individuals may reflect timing of the CHiP visit, with
the CHiP visiting the household before the test had been
used, but also reflect the intended user’s decision not to
share information on use of the self-test kit. A longer
reporting period might have seen the intermediary report be
more reflective of returned test kits. Alternative methods for
measuring use and facilitating HIVST kit return, particularly
where HIVST is through secondary distribution, need to be
explored if higher HTS uptake is to be translated into
increased coverage of treatment and prevention services.
Providing alternative ways for individuals to return kits and
use of barcodes is recommended, as these allowed us to link
kits to information on distribution and use as reported by
intermediary individuals. Use of mobile phones to report
HIVST kit use and provide information on prevention and
care services should also be explored. A small number of
individuals with a reactive result were seen by the CHiP
during the study. A longer follow-up period for this analysis
may have seen more individuals with a reactive HIVST
followed-up by CHiPs, who were familiar with the commu-
nities and likely knew the intended users. Future research
should collect data on who the intended user is to allow
researchers to understand who is not being reached or not
linked to care through secondary distribution.
At the time of implementation, HIVST was novel. The
implementation period may have been too short to allow
communities to adapt to HIVST.20 While CHiPs had been
offering HTS for ;3 years, HIVST was also new to CHiPs,
with secondary distribution particularly novel. CHiPs may
have felt that secondary distribution relinquished their role as
lay counselors. The strategy proved labor intensive, requiring
detailed explanations on how to explain HIVST to a third
party. A longer implementation period may have seen more
kits distributed for secondary use.
Our data were subject to limitations. As mentioned, we
did not have data on the number of individuals consenting to
PopART who, at the first CHiP household visit, had a partner
that was absent. As such, our analysis underestimates
acceptance of secondary distribution HIVST kits among
individuals with an absent partner and likely underestimates
reach among absent partners. Some CHiPs struggled with
TABLE 3. Sex and Age (N = 533) Distribution of Individuals
Who Used a Secondary Distribution HIV Self-Testing Kit*
(Outcome 4)
Number Percent (Col%)
Sex and age distribution
Male ,30 131 24.6%
Male 30+ 315 59.1%
Female ,30 33 6.2%
Female 30+ 54 10.1%
*Age of user was missing for 10, and sex of user for an additional 1 HIVST kit.
TABLE 4. Use of a Secondary Distribution HIVST Kit by Individuals Known to CHiPs (n = 276) Among Individuals Absent at the










HIVST Kit Odds Ratio (OR; 95% CI)* Adjusted OR (95% CI)† P‡
Overall 5935 276 4.7%
Sex
Male 3704 62.4% 256 6.9% 1.0 1.0 ,0.001
Female 2231 37.6% 20 0.9% 0.13 (0.09 to 0.19) 0.14 (0.09 to 0.21)
Age
,30 2820 47.5% 83 2.9% 1.0 1.0 ,0.001
30+ 3115 52.5% 193 6.2% 2.13 (1.50 to 3.03) 2.00 (1.38 to 2.90)
Previously resident in the same CHiP zone
No 1520 25.6% 111 7.3% 1.0 1.0 0.002
Yes 4415 74.4% 165 3.7% 0.51 (0.36 to 0.71) 0.59 (0.42 to 0.81)
Participation and knowledge of HIV status in previous
rounds of PopART service delivery
Did not participate in round 1 (R1)/round 2 (R2) of
PopART
2480 41.8% 171 6.9% 1.0 1.0 ,0.001
Not HIV-tested in R1/R2 692 11.7% 30 4.3% 0.57 (0.40 to 0.81) 0.58 (0.41 to 0.81)
Tested HIV negative in R1/R2 2467 41.7% 73 3.0% 0.09 (0.02 to 0.37) 0.11 (0.03 to 0.44)
Known HIV+ at R1/R2§ 296 5.0% 2 0.7% 0.43 (0.31 to 0.61) 0.57 (0.41 to 0.81)
R refers to rounds of PopART service delivery (R1—round 1, R2—round 2); the current study was nested in a third round of PopART service delivery.
*Accounting for clustering by zone.
†Adjusted for sex, age, and community, and accounting for clustering by zone.
‡P value from the Wald test.
§Either self-reported HIV-positive or newly diagnosed HIV-positive.
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data entry for secondary distribution. We accounted for these
in the analysis, yet some individuals with a secondary
distribution HIVST kit result were not linked to an interme-
diary individual, particularly if they resided in large house-
holds, as more assumptions about relationships within
households would have been required. Using data on returned
kits, we were strict in our definition of evidence of use,
excluding kits recorded as used but without an SCR form. In
excluding these kits, our study may underestimate kits for
which there is evidence of use. Data were primarily self-
reported, and because of the nature of HIVST, we cannot be
sure who used the kit. Rigorous measurement of use of
HIVST kits remains a challenge.
The EDC system collected data on service delivery and
uptake. Although these data presented some challenges for
this analysis, data were collected systematically on all
households and are a valuable resource to understand
intervention coverage among a large population. The database
on returned HIVST kits was not developed with research
in mind, yet provided valuable information to complement
self-report. Additional strengths are: we have been transparent
about challenges and assumptions, highlight the importance
of program data and opportunities for learning where such
data are used strategically.27 Findings are generalizable to
high prevalence HIV settings with regular exposure to HTS.
CONCLUSIONS
Community-based secondary distribution HIVST kits
were used by men and those older than 30 years, who are
missed by current HTS.2 To increase reach and better
understand service use, targeted secondary distribution strate-
gies need to be developed and tested, including distribution
through social networks, and innovative ways of encouraging
test-kit return explored. To improve targeting, existing data on
HTS uptake through different strategies need to be consoli-
dated to understand key demographic groups that remain
unreached and establish how these groups could be reached
through secondary distribution as part of a UTT strategy.
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